{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:18:34Z","timestamp":1773296314611,"version":"3.50.1"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Roche Netherlands B.V. Activaero GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Pulmonol."],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/ppul.22800","type":"journal-article","created":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T11:42:53Z","timestamp":1372851773000},"page":"154-161","source":"Crossref","is-referenced-by-count":9,"title":["Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial"],"prefix":"10.1002","volume":"49","author":[{"given":"E.M.","family":"Bakker","sequence":"first","affiliation":[{"name":"Department of Paediatric Pulmonology and Allergology; Erasmus MC-Sophia Children's Hospital; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Volpi","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Centre; Azienda Ospedaliera di Verona; Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Salonini","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Centre; Azienda Ospedaliera di Verona; Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"M\u00fcllinger","sequence":"additional","affiliation":[{"name":"Activaero GmbH; Gem\u00fcnden Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kroneberg","sequence":"additional","affiliation":[{"name":"Activaero GmbH; Gem\u00fcnden Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Department of Pulmonology; Erasmus MC; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.C.J.","family":"Hop","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Erasmus MC; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"Assael","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Centre; Azienda Ospedaliera di Verona; Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.W.M.","family":"Tiddens","sequence":"additional","affiliation":[{"name":"Department of Paediatric Pulmonology and Allergology; Erasmus MC-Sophia Children's Hospital; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"key":"10.1002\/ppul.22800-BIB0001|ppul22800-cit-0001","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/ajrccm.165.7.2010139","article-title":"Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis","volume":"165","author":"Dakin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0002|ppul22800-cit-0002","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"156","author":"Armstrong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0003|ppul22800-cit-0003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/adc.87.4.306","article-title":"Early airway infection, inflammation, and lung function in cystic fibrosis","volume":"87","author":"Nixon","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1002\/ppul.22800-BIB0004|ppul22800-cit-0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ppul.21154","article-title":"Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively","volume":"45","author":"Tiddens","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0005|ppul22800-cit-0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0006|ppul22800-cit-0006","doi-asserted-by":"crossref","first-page":"623.e621","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22800-BIB0007|ppul22800-cit-0007","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.200804-551OC","article-title":"Lung function in infants with cystic fibrosis diagnosed by newborn screening","volume":"178","author":"Linnane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0008|ppul22800-cit-0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1164\/rccm.200407-895OC","article-title":"Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis","volume":"171","author":"Aurora","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0009|ppul22800-cit-0009","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/thx.2008.110908","article-title":"The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease","volume":"64","author":"Loeve","year":"2009","journal-title":"Thorax"},{"key":"10.1002\/ppul.22800-BIB0010|ppul22800-cit-0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/ajrccm\/142.5.1053","article-title":"The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum","volume":"142","author":"Lethem","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/ppul.22800-BIB0011|ppul22800-cit-0011","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld","year":"2001","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22800-BIB0012|ppul22800-cit-0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.21117","article-title":"Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis","volume":"45","author":"Sanders","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0013|ppul22800-cit-0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0014|ppul22800-cit-0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1002\/ppul.22800-BIB0015|ppul22800-cit-0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MCP.0b013e32834b8c04","article-title":"Pulmonary exacerbations in cystic fibrosis","volume":"17","author":"Stenbit","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1002\/ppul.22800-BIB0016|ppul22800-cit-0016","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0017|ppul22800-cit-0017","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ppul.22800-BIB0018|ppul22800-cit-0018","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/ppul.22800-BIB0019|ppul22800-cit-0019","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1183\/09031936.95.08101786","article-title":"DNase trials in cystic fibrosis","volume":"8","author":"Hodson","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0020|ppul22800-cit-0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22800-BIB0021|ppul22800-cit-0021","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1164\/ajrccm.153.6.8665055","article-title":"Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations","volume":"153","author":"Wilmott","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0022|ppul22800-cit-0022","first-page":"CD001127","article-title":"Recombinant human deoxyribonuclease for cystic fibrosis","volume":"(3)","author":"Jones","year":"2003","journal-title":"Cochrane Database Sys Rev (Online)"},{"key":"10.1002\/ppul.22800-BIB0023|ppul22800-cit-0023","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1164\/ajrccm.156.5.9604093","article-title":"RhDNase I aerosol deposition and related factors in cystic fibrosis","volume":"156","author":"Diot","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0024|ppul22800-cit-0024","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1378\/chest.118.4.1069","article-title":"Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate","volume":"118","author":"Laube","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1002\/ppul.22800-BIB0025|ppul22800-cit-0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jam.2005.18.45","article-title":"Optimum peripheral drug deposition in patients with cystic fibrosis","volume":"18","author":"Brand","year":"2005","journal-title":"J Aerosol Med"},{"key":"10.1002\/ppul.22800-BIB0026|ppul22800-cit-0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1183\/09031936.03.00096802","article-title":"Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices","volume":"22","author":"Brand","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0027|ppul22800-cit-0027","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200308-1104OC","article-title":"Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis","volume":"169","author":"Griese","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0028|ppul22800-cit-0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-0496(199802)25:2<83::AID-PPUL2>3.0.CO;2-O","article-title":"Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group","volume":"25","author":"Geller","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0029|ppul22800-cit-0029","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1183\/09031936.00006211","article-title":"Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation","volume":"38","author":"Bakker","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0030|ppul22800-cit-0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/jam.2005.18.386","article-title":"Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients","volume":"18","author":"Kohler","year":"2005","journal-title":"J Aerosol Med"},{"key":"10.1002\/ppul.22800-BIB0031|ppul22800-cit-0031","first-page":"169","volume-title":"Monduzzi Editore, Genua","author":"Scheuch","year":"2002"},{"key":"10.1002\/ppul.22800-BIB0032|ppul22800-cit-0032","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.00118408","article-title":"Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency","volume":"34","author":"Brand","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0033|ppul22800-cit-0033","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1183\/09031936.97.10112479","article-title":"Comparison of drug delivery from conventional versus \u201cVenturi\u201d nebulizers","volume":"10","author":"Devadason","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0034|ppul22800-cit-0034","first-page":"174","article-title":"Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric","volume":"49","author":"Rau","year":"2004","journal-title":"Respir Care"},{"key":"10.1002\/ppul.22800-BIB0035|ppul22800-cit-0035","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1183\/09031936.94.07061177","article-title":"Efficient drug delivery to the lungs from a continuously operated open-vent nebulizer and low pressure compressor system","volume":"7","author":"Newman","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0036|ppul22800-cit-0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0954-6111(93)90074-A","article-title":"Lung deposition from four nebulizers","volume":"87","author":"Hardy","year":"1993","journal-title":"Respir Med"},{"key":"10.1002\/ppul.22800-BIB0037|ppul22800-cit-0037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"key":"10.1002\/ppul.22800-BIB0038|ppul22800-cit-0038","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.105.2.405","article-title":"Nocturnal pulse oximetry as an abbreviated testing modality for pediatric obstructive sleep apnea","volume":"105","author":"Brouillette","year":"2000","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22800-BIB0039|ppul22800-cit-0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1378\/chest.123.1.96","article-title":"Reference values for nocturnal home pulse oximetry during sleep in primary school children","volume":"123","author":"Urschitz","year":"2003","journal-title":"Chest"},{"key":"10.1002\/ppul.22800-BIB0040|ppul22800-cit-0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1183\/09031936.00031107","article-title":"Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up","volume":"30","author":"van der Giessen","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0041|ppul22800-cit-0041","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ppul.20636","article-title":"RhDNase before airway clearance therapy improves airway patency in children with CF","volume":"42","author":"van der Giessen","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0042|ppul22800-cit-0042","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.98.11020462","article-title":"Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method","volume":"11","author":"Chang","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1002\/ppul.22800-BIB0043|ppul22800-cit-0043","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","article-title":"Reference ranges for spirometry across all ages: a new approach","volume":"177","author":"Stanojevic","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22800-BIB0044|ppul22800-cit-0044","first-page":"343","article-title":"[Significance of contemporary methods of lung function testing for the detection of airway obstruction in children and adolescents (author's transl)] Die Bedeutung heutiger Methoden der Lungenfunktionsdiagnostik zur Feststellung einer Obstruktion der Atemwege bei Kindern und Jugendlichen","volume":"149","author":"Zapletal","year":"1977","journal-title":"Z Erkr Atmungsorgane"},{"key":"10.1002\/ppul.22800-BIB0045|ppul22800-cit-0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ppul.1950160605","article-title":"Evolution of pulmonary function during an acute, exacerbation in hospitalized patients with cystic fibrosis","volume":"16","author":"Gozal","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0046|ppul22800-cit-0046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ppul.1072","article-title":"Defining an exacerbation of pulmonary disease in cystic fibrosis","volume":"31","author":"Dakin","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0047|ppul22800-cit-0047","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcf.2011.11.005","article-title":"Patient indicators of a pulmonary exacerbation: preliminary reports from school aged children map onto those of adults","volume":"11","author":"Abbott","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.22800-BIB0048|ppul22800-cit-0048","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1023\/A:1016294805680","article-title":"Aerosol deposition as a function of airway disease: cystic fibrosis","volume":"12","author":"Martonen","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/ppul.22800-BIB0049|ppul22800-cit-0049","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1378\/chest.101.5.1302","article-title":"Radioaerosol assessment of lung improvement in cystic fibrosis patients treated for acute pulmonary exacerbations","volume":"101","author":"Laube","year":"1992","journal-title":"Chest"},{"key":"10.1002\/ppul.22800-BIB0050|ppul22800-cit-0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/ajrccm\/148.1.145","article-title":"Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis","volume":"148","author":"Ramsey","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/ppul.22800-BIB0051|ppul22800-cit-0051","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(93)92297-7","article-title":"Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis","volume":"342","author":"Ranasinha","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/ppul.22800-BIB0052|ppul22800-cit-0052","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"key":"10.1002\/ppul.22800-BIB0053|ppul22800-cit-0053","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"10.1002\/ppul.22800-BIB0054|ppul22800-cit-0054","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials","volume":"10","author":"Bilton","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.22800-BIB0055|ppul22800-cit-0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22800-BIB0056|ppul22800-cit-0056","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/AAC.00174-09","article-title":"Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis","volume":"53","author":"Hubert","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/ppul.22800-BIB0057|ppul22800-cit-0057","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2010.09.003","article-title":"Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis","volume":"10","author":"Adeboyeku","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.22800-BIB0058|ppul22800-cit-0058","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcf.2007.07.001","article-title":"Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis","volume":"7","author":"Latzin","year":"2008","journal-title":"J Cyst Fibros"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22800","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ppul.22800\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T21:18:41Z","timestamp":1688332721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.22800"}},"subtitle":["Dornase Alfa for the Small Airways in CF: DEPTH"],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/ppul.22800","archive":["Portico"],"relation":{},"ISSN":["8755-6863"],"issn-type":[{"value":"8755-6863","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}